Annual report
9220.TEDINET S100PETN
Period2021-04-01 → 2022-03-31
Filed2022-10-27
StandardJapan GAAP
ConsolidatedYes
Data checks24 of 24 passed
Amends S100OI1Z.
Key figures · 114
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥9.2bn | 2021-04-01 → 2022-03-31 | Cons. | Net sales |
| Revenue | ¥9.4bn | 2020-04-01 → 2021-03-31 | Cons. | Net sales |
| Revenue | ¥9.0bn | 2019-04-01 → 2020-03-31d | Cons. | Net sales (5-year summary) |
| Operating income | ¥650m | 2021-04-01 → 2022-03-31 | Cons. | Operating income |
| Operating income | ¥528m | 2020-04-01 → 2021-03-31 | Cons. | Operating income |
| Ordinary income | ¥648m | 2021-04-01 → 2022-03-31 | Cons. | Ordinary income |
| Ordinary income | ¥608m | 2020-04-01 → 2021-03-31 | Cons. | Ordinary income |
| Ordinary income | ¥532m | 2019-04-01 → 2020-03-31d | Cons. | Ordinary income loss (5-year summary) |
| Profit before tax | ¥710m | 2021-04-01 → 2022-03-31 | Cons. | Income before income taxes |
| Profit before tax | ¥677m | 2020-04-01 → 2021-03-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥529m | 2021-04-01 → 2022-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥477m | 2020-04-01 → 2021-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥486m | 2019-04-01 → 2020-03-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income | ¥529m | 2021-04-01 → 2022-03-31 | Cons. | Profit loss |
| Net income | ¥472m | 2020-04-01 → 2021-03-31 | Cons. | Profit loss |
| Total assets | ¥7.7bn | at 2022-03-31 | Cons. | Assets |
| Total assets | ¥8.3bn | at 2021-03-31 | Cons. | Assets |
| Total assets | ¥8.0bn | at 2020-03-31d | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥5.7bn | at 2022-03-31 | Cons. | Liabilities |
| Total liabilities | ¥6.8bn | at 2021-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥2.0bn | at 2022-03-31 | Cons. | Net assets |
| Net assets / equity | ¥1.5bn | at 2021-03-31 | Cons. | Net assets |
| Net assets / equity | ¥632m | at 2020-03-31d | Cons. | Net assets |
| Cash and deposits | ¥1.8bn | at 2022-03-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥1.9bn | at 2021-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥1.6bn | at 2022-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥1.7bn | at 2021-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥976m | at 2020-03-31d | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥899m | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥1.2bn | 2020-04-01 → 2021-03-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥847m | 2019-04-01 → 2020-03-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Investing cash flow | −¥97m | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥112m | 2020-04-01 → 2021-03-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥130m | 2019-04-01 → 2020-03-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Financing cash flow | −¥879m | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥374m | 2020-04-01 → 2021-03-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥370m | 2019-04-01 → 2020-03-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| EPS (basic) | ¥240.32 | 2021-04-01 → 2022-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥238.53 | 2020-04-01 → 2021-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥242.76 | 2019-04-01 → 2020-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| Net assets per share | ¥913.16 | at 2022-03-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥673.99 | at 2021-03-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥313.17 | at 2020-03-31d | Cons. | Net assets per share (5-year summary) |
| Equity ratio | 26.1% | at 2022-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 17.8% | at 2021-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 7.9% | at 2020-03-31d | Cons. | Equity to asset ratio (5-year summary) |
| ROE | 30.3% | 2021-04-01 → 2022-03-31 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 45.3% | 2020-04-01 → 2021-03-31 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 76.8% | 2019-04-01 → 2020-03-31d | Cons. | Rate of return on equity (5-year summary) |
| Employees | 985 | at 2022-03-31 | Cons. | Number of employees |
| Employees | 999 | at 2021-03-31 | Cons. | Number of employees |
| Employees | 1,051 | at 2020-03-31d | Cons. | Number of employees |
| Revenue | ¥8.8bn | 2021-04-01 → 2022-03-31 | Standalone | Net sales |
| Revenue | ¥8.1bn | 2020-04-01 → 2021-03-31 | Standalone | Net sales |
| Revenue | ¥7.6bn | 2019-04-01 → 2020-03-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥7.1bn | 2018-04-01 → 2019-03-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥6.1bn | 2017-04-01 → 2018-03-31d | Standalone | Net sales (5-year summary) |
| Operating income | ¥581m | 2021-04-01 → 2022-03-31 | Standalone | Operating income |
| Operating income | ¥470m | 2020-04-01 → 2021-03-31 | Standalone | Operating income |
| Ordinary income | ¥578m | 2021-04-01 → 2022-03-31 | Standalone | Ordinary income |
| Ordinary income | ¥546m | 2020-04-01 → 2021-03-31 | Standalone | Ordinary income |
| Ordinary income | ¥581m | 2019-04-01 → 2020-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥420m | 2018-04-01 → 2019-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥172m | 2017-04-01 → 2018-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Profit before tax | ¥548m | 2021-04-01 → 2022-03-31 | Standalone | Income before income taxes |
| Profit before tax | ¥745m | 2020-04-01 → 2021-03-31 | Standalone | Income before income taxes |
| Net income | ¥368m | 2021-04-01 → 2022-03-31 | Standalone | Profit loss |
| Net income | ¥502m | 2020-04-01 → 2021-03-31 | Standalone | Profit loss |
| Net income | ¥495m | 2019-04-01 → 2020-03-31d | Standalone | Net income loss (5-year summary) |
| Net income | ¥236m | 2018-04-01 → 2019-03-31d | Standalone | Net income loss (5-year summary) |
| Net income | −¥46m | 2017-04-01 → 2018-03-31d | Standalone | Net income loss (5-year summary) |
| Total assets | ¥7.5bn | at 2022-03-31 | Standalone | Assets |
| Total assets | ¥7.8bn | at 2021-03-31 | Standalone | Assets |
| Total assets | ¥7.2bn | at 2020-03-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥7.3bn | at 2019-03-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥7.4bn | at 2018-03-31d | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥5.6bn | at 2022-03-31 | Standalone | Liabilities |
| Total liabilities | ¥6.3bn | at 2021-03-31 | Standalone | Liabilities |
| Net assets / equity | ¥1.9bn | at 2022-03-31 | Standalone | Net assets |
| Net assets / equity | ¥1.5bn | at 2021-03-31 | Standalone | Net assets |
| Net assets / equity | ¥663m | at 2020-03-31d | Standalone | Net assets |
| Net assets / equity | ¥688m | at 2019-03-31d | Standalone | Net assets (5-year summary) |
| Net assets / equity | ¥450m | at 2018-03-31d | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥1.6bn | at 2022-03-31 | Standalone | Cash and deposits |
| Cash and deposits | ¥1.7bn | at 2021-03-31 | Standalone | Cash and deposits |
| EPS (basic) | ¥167.07 | 2021-04-01 → 2022-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥250.97 | 2020-04-01 → 2021-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥247.56 | 2019-04-01 → 2020-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥1,180,342.28 | 2018-04-01 → 2019-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-228,316.14 | 2017-04-01 → 2018-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| Net assets per share | ¥860.61 | at 2022-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥694.69 | at 2021-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥331.59 | at 2020-03-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥3,441,562.86 | at 2019-03-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥2,249,658.08 | at 2018-03-31d | Standalone | Net assets per share (5-year summary) |
| Equity ratio | 25.2% | at 2022-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 19.5% | at 2021-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 9.2% | at 2020-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 9.4% | at 2019-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 6.0% | at 2018-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| ROE | 21.5% | 2021-04-01 → 2022-03-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 45.8% | 2020-04-01 → 2021-03-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 73.3% | 2019-04-01 → 2020-03-31d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 41.5% | 2018-04-01 → 2019-03-31d | Standalone | Rate of return on equity (5-year summary) |
| Shares issued | 2,200,000 | at 2022-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 2,200,000 | at 2021-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 200 | at 2020-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 200 | at 2019-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 200 | at 2018-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Employees | 938 | at 2022-03-31 | Standalone | Number of employees |
| Employees | 888 | at 2021-03-31 | Standalone | Number of employees |
| Employees | 840 | at 2020-03-31d | Standalone | Number of employees |
| Employees | 785 | at 2019-03-31d | Standalone | Number of employees |
| Employees | 729 | at 2018-03-31d | Standalone | Number of employees |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 48
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | capex | 2021-04-01 → 2022-03-31 | ¥6m |
| Reconciling Itemsreconciling | segment assets | at 2022-03-31 | ¥2.2bn |
| Nursing Care Businessreportable segment | capex | 2021-04-01 → 2022-03-31 | ¥59m |
| Nursing Care Businessreportable segment | depreciation | 2021-04-01 → 2022-03-31 | ¥282m |
| Nursing Care Businessreportable segment | employees | at 2022-03-31 | 643 pure |
| Nursing Care Businessreportable segment | revenue | 2021-04-01 → 2022-03-31 | ¥5.1bn |
| Nursing Care Businessreportable segment | revenue external | 2021-04-01 → 2022-03-31 | ¥5.1bn |
| Nursing Care Businessreportable segment | segment assets | at 2022-03-31 | ¥4.3bn |
| Nursing Care Businessreportable segment | segment profit | 2021-04-01 → 2022-03-31 | ¥378m |
| Nursing Care Equipment Businessreportable segment | capex | 2021-04-01 → 2022-03-31 | ¥14m |
| Nursing Care Equipment Businessreportable segment | depreciation | 2021-04-01 → 2022-03-31 | ¥27m |
| Nursing Care Equipment Businessreportable segment | employees | at 2022-03-31 | 285 pure |
| Nursing Care Equipment Businessreportable segment | revenue | 2021-04-01 → 2022-03-31 | ¥4.0bn |
| Nursing Care Equipment Businessreportable segment | revenue external | 2021-04-01 → 2022-03-31 | ¥4.0bn |
| Nursing Care Equipment Businessreportable segment | segment assets | at 2022-03-31 | ¥1.1bn |
| Nursing Care Equipment Businessreportable segment | segment profit | 2021-04-01 → 2022-03-31 | ¥272m |
| Total Of Reportable Segments And Otherssegment total | capex | 2021-04-01 → 2022-03-31 | ¥73m |
| Total Of Reportable Segments And Otherssegment total | depreciation | 2021-04-01 → 2022-03-31 | ¥309m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2021-04-01 → 2022-03-31 | ¥9.2bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2021-04-01 → 2022-03-31 | ¥9.2bn |
| Total Of Reportable Segments And Otherssegment total | segment assets | at 2022-03-31 | ¥5.5bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2021-04-01 → 2022-03-31 | ¥650m |
| Reconciling Itemsreconciling | capex | 2020-04-01 → 2021-03-31 | ¥6m |
| Reconciling Itemsreconciling | revenue | 2020-04-01 → 2021-03-31 | −¥1m |
| Reconciling Itemsreconciling | revenue intersegment | 2020-04-01 → 2021-03-31 | −¥1m |
| Reconciling Itemsreconciling | segment assets | at 2021-03-31 | ¥2.3bn |
| Nursing Care Businessreportable segment | capex | 2020-04-01 → 2021-03-31 | ¥227m |
| Nursing Care Businessreportable segment | depreciation | 2020-04-01 → 2021-03-31 | ¥303m |
| Nursing Care Businessreportable segment | revenue | 2020-04-01 → 2021-03-31 | ¥5.6bn |
| Nursing Care Businessreportable segment | revenue external | 2020-04-01 → 2021-03-31 | ¥5.6bn |
| Nursing Care Businessreportable segment | segment assets | at 2021-03-31 | ¥4.9bn |
| Nursing Care Businessreportable segment | segment profit | 2020-04-01 → 2021-03-31 | ¥206m |
| Nursing Care Equipment Businessreportable segment | capex | 2020-04-01 → 2021-03-31 | ¥3m |
| Nursing Care Equipment Businessreportable segment | depreciation | 2020-04-01 → 2021-03-31 | ¥28m |
| Nursing Care Equipment Businessreportable segment | revenue | 2020-04-01 → 2021-03-31 | ¥3.8bn |
| Nursing Care Equipment Businessreportable segment | revenue external | 2020-04-01 → 2021-03-31 | ¥3.8bn |
| Nursing Care Equipment Businessreportable segment | revenue intersegment | 2020-04-01 → 2021-03-31 | ¥1m |
| Nursing Care Equipment Businessreportable segment | segment assets | at 2021-03-31 | ¥1.1bn |
| Nursing Care Equipment Businessreportable segment | segment profit | 2020-04-01 → 2021-03-31 | ¥322m |
| Total Of Reportable Segments And Otherssegment total | capex | 2020-04-01 → 2021-03-31 | ¥230m |
| Total Of Reportable Segments And Otherssegment total | depreciation | 2020-04-01 → 2021-03-31 | ¥331m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2020-04-01 → 2021-03-31 | ¥9.4bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2020-04-01 → 2021-03-31 | ¥9.4bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2020-04-01 → 2021-03-31 | ¥1m |
| Total Of Reportable Segments And Otherssegment total | segment assets | at 2021-03-31 | ¥6.0bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2020-04-01 → 2021-03-31 | ¥528m |
| Nursing Care Businessreportable segment | employees | at 2022-03-31 | 596 pure |
| Nursing Care Equipment Businessreportable segment | employees | at 2022-03-31 | 285 pure |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 1,348
| Item | Context | Value | Unit |
|---|---|---|---|
| Price earnings ratio (5-year summary) | Prior1YearDuration_NonConsolidatedMember | － | |
| Price earnings ratio (5-year summary) | CurrentYearDuration_NonConsolidatedMember | － | |
| Payout ratio (5-year summary) | Prior4YearDuration_NonConsolidatedMember | － | |
| Payout ratio (5-year summary) | Prior3YearDuration_NonConsolidatedMember | － | |
| Payout ratio (5-year summary) | Prior2YearDuration_NonConsolidatedMember | － | |
| Payout ratio (5-year summary) | Prior1YearDuration_NonConsolidatedMember | － | |
| Payout ratio (5-year summary) | CurrentYearDuration_NonConsolidatedMember | － | |
| Number of employees | Prior4YearInstant_NonConsolidatedMember | 729 | |
| Number of employees | Prior3YearInstant_NonConsolidatedMember | 785 | |
| Number of employees | Prior2YearInstant_NonConsolidatedMember | 840 | |
| Number of employees | Prior1YearInstant_NonConsolidatedMember | 888 | |
| Number of employees | CurrentYearInstant_NonConsolidatedMember | 938 | |
| Average number of temporary workers | Prior4YearInstant_NonConsolidatedMember | 228 | |
| Average number of temporary workers | Prior3YearInstant_NonConsolidatedMember | 138 | |
| Average number of temporary workers | Prior2YearInstant_NonConsolidatedMember | 141 | |
| Average number of temporary workers | Prior1YearInstant_NonConsolidatedMember | 161 | |
| Average number of temporary workers | CurrentYearInstant_NonConsolidatedMember | 171 | |
| Total shareholder return | Prior4YearInstant_NonConsolidatedMember | － | |
| Total shareholder return | Prior3YearInstant_NonConsolidatedMember | － | |
| Total shareholder return | Prior2YearInstant_NonConsolidatedMember | － | |
| Total shareholder return | Prior1YearInstant_NonConsolidatedMember | － | |
| Total shareholder return | CurrentYearInstant_NonConsolidatedMember | － | |
| Total return on share price index | Prior4YearInstant_NonConsolidatedMember | － | |
| Total return on share price index | Prior3YearInstant_NonConsolidatedMember | － | |
| Total return on share price index | Prior2YearInstant_NonConsolidatedMember | － | |
| Total return on share price index | Prior1YearInstant_NonConsolidatedMember | － | |
| Total return on share price index | CurrentYearInstant_NonConsolidatedMember | － | |
| Number of employees | CurrentYearInstant_jpcrp030000-asr_E37523-000NursingCareEquipmentBusinessReportableSegmentMember | 285 | |
| Average number of temporary workers | CurrentYearInstant_jpcrp030000-asr_E37523-000NursingCareEquipmentBusinessReportableSegmentMember | 13 | |
| Number of employees | CurrentYearInstant_jpcrp030000-asr_E37523-000NursingCareBusinessReportableSegmentMember | 643 | |
| Average number of temporary workers | CurrentYearInstant_jpcrp030000-asr_E37523-000NursingCareBusinessReportableSegmentMember | 170 | |
| Number of employees | CurrentYearInstant_CorporateSharedMember | 57 | |
| Average number of temporary workers | CurrentYearInstant_CorporateSharedMember | 5 | |
| Number of employees | CurrentYearInstant | 985 | |
| Average number of temporary workers | CurrentYearInstant | 188 | |
| Number of employees | CurrentYearInstant_NonConsolidatedMember | 938 | |
| Average number of temporary workers | CurrentYearInstant_NonConsolidatedMember | 171 | |
| Average age years information about reporting company information about employees | CurrentYearInstant_NonConsolidatedMember | 44.8 | |
| Average length of service years information about reporting company information about employees | CurrentYearInstant_NonConsolidatedMember | 5.5 | |
| Average annual salary information about reporting company information about employees | CurrentYearInstant_NonConsolidatedMember | 3808000 | JPY |
| Number of employees | CurrentYearInstant_NonConsolidatedMember_jpcrp030000-asr_E37523-000NursingCareEquipmentBusinessReportableSegmentMember | 285 | |
| Average number of temporary workers | CurrentYearInstant_NonConsolidatedMember_jpcrp030000-asr_E37523-000NursingCareEquipmentBusinessReportableSegmentMember | 13 | |
| Number of employees | CurrentYearInstant_NonConsolidatedMember_jpcrp030000-asr_E37523-000NursingCareBusinessReportableSegmentMember | 596 | |
| Average number of temporary workers | CurrentYearInstant_NonConsolidatedMember_jpcrp030000-asr_E37523-000NursingCareBusinessReportableSegmentMember | 153 | |
| Number of employees | CurrentYearInstant_NonConsolidatedMember_CorporateSharedMember | 57 | |
| Average number of temporary workers | CurrentYearInstant_NonConsolidatedMember_CorporateSharedMember | 5 | |
| Number of employees | CurrentYearInstant_NonConsolidatedMember | 938 | |
| Average number of temporary workers | CurrentYearInstant_NonConsolidatedMember | 171 | |
| Capital expenditures overview of capital expenditures etc | CurrentYearDuration | 61977000 | JPY |
| Number of issued shares as of fiscal year end issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | 2200000 |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 24 of 24 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |